English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Aids Institute
John Breslin
| Oct 27, 2017
CMS administrator urged to prevent states from restricting hepatitis C drug access
Nicholas Gueguen
| Aug 13, 2017
House Appropriations Committee decides to keep funding for several programs in HIV, hepatitis fight
Robert Hadley
| Jun 2, 2017
FDA approves higher once-a-day dose of Merck’s Isentress HIV drug
Erianne Leatherman
| May 16, 2017
AIDS Alliance working with Advocates for Youth to boost AIDS/HIV awareness
Erianne Leatherman
| Mar 15, 2017
Updates to National Viral Hepatitis Action Plan include strategies to prevent infection
Vimbai Chikomo
| Apr 6, 2016
Obamacare is failing to discipline Florida insurers for discriminating against hepatitis C patients, according to expert
Jamie Barrand
| Dec 24, 2015
The AIDS Institute officials laud rejection of HIV funding cuts
Katelyn Kivel
| Nov 3, 2015
Cigna leaves Florida exchange amid HIV discrimination allegations
Trending
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 17, 2025
UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+
Pharmaceuticals
Patient Daily
| Apr 22, 2025
National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+
Pharmaceuticals
Patient Daily
| Apr 23, 2025
State Sen. Baldacci: 340B reform ‘could help hospitals alone to the tune of 50 to 70 million per year'
